Show Notes
Dose of Discovery is a monthly science podcast about the people, ideas, and challenges shaping modern biomedicine.
Tune in as hosts Søren and AJ have thoughtful, accessible conversations with leading scientists about complex subjects, following emerging therapeutics as they move from research to real-world impact.
Dose of Discovery — BioXconomy’s flagship podcast — is for biotech professionals, researchers, and curious listeners alike. Subscribe now for your regular dose of breakthrough medical discoveries delivered with your morning coffee. (Coffee not included).
Read more at BioXconomy: https://bioxconomy.com/ Check out our upcoming events: https://www.bioxconomy.com/events
7898c6b0-4922-11f1-be3b-27c072cdfbe0 Hosted on Acast. See acast.com/privacy for more information.
More from Dose of Discovery
Decades of curiosity and determination helped Katalin Karikó turn overlooked research into a technology that changed the course of a pandemic. The mRNA pioneer and Nobel laureate joins Søren and AJ to discuss how she navigated demotion and threats of deportation to find peace and joy in the lab.
What can cone snail venom teach us about peptides and new medicines?
CRISPR pioneer Erik Sontheimer joins hosts Søren and AJ to discuss how curiosity-driven research revealed a powerful genome editing technology.
It may seem obvious, but not all drugs are manufacturable. Getting an exciting new treatment from the lab to patients is only possible if the molecule or substance itself is scalable.
In this episode of Dose of Discovery, hosts Søren and AJ speak to physician-scientist Stanley Crooke, CEO of the nonprofit n-Lorem Foundation, about how antisense oligonucleotide (ASO) technology has evolved into a revolutionary therapeutic modality.